Latest Period
Q2 2026
Security Snapshot
HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE) Institutional Ownership
CUSIP: 405024100
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
328
Shares (Excl. Options)
49,618,196
Price
$75.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $0.01 par value per share
- Symbol
- HAE on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 49,618,196
- Total 13F value
- $3,714,683,966
- Portfolio coverage rank
- 0%
- Share change
- +2,041,743
- Value change
- +$181,716,307
- Number of holders
- 328
- Shares outstanding
- 45,420,621
- SEC-reported price per share
- $75.00
- Insider filing price
- $75.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share is tracked under CUSIP 405024100.
- 328 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 324 to 328 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,681,997,623 to $3,714,683,966.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 328 institutions filings for Q2 2026.
Security key
405024100
Latest holder period
Q2 2026
13F holders
328
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
HAE full holder history
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
HAEMONETICS CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 405024100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
HAE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | $146,544,172 | 2,600,145 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $137,846,246 | 2,445,817 | Vanguard Capital Management | 31 Mar 2026 | |||
| AQR CAPITAL MANAGEMENT LLC | 5% | -25% | $169,986,675 | -$67,246,125 | 2,266,489 | -28% | AQR Capital Management, LLC | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.6% | -16% | $165,537,761 | -$36,448,193 | 2,203,351 | -18% | Wellington Management Group LLP | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. | 4.4% | $135,949,632 | 2,195,569 | T. Rowe Price Investment Management, Inc. | 31 Mar 2025 | |||
| Capital Research Global Investors | 3.1% | $97,667,840 | 1,577,323 | Capital Research Global Investors | 31 Mar 2025 |
As of 30 Jun 2026, 328 institutional investors reported holding 49,618,196 shares of HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE). This represents 109% of the company’s total 45,420,621 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
82%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 5,909,258 | +5.1% | 0.01% | $443,194,350 |
| NEUBERGER BERMAN GROUP LLC | 9.2% | 4,179,443 | +17% | 0.21% | $313,473,399 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | 2,546,394 | -0.5% | 0.01% | $190,979,550 |
| AQR CAPITAL MANAGEMENT LLC | 5% | 2,266,489 | -32% | 0.06% | $165,023,065 |
| ARIEL INVESTMENTS, LLC | 4.5% | 2,060,966 | 1.5% | $154,572,450 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,059,578 | -1.5% | 0% | $154,468,350 |
| STATE STREET CORP | 4% | 1,818,186 | +2.6% | 0% | $136,363,950 |
| DIMENSIONAL FUND ADVISORS LP | 3.5% | 1,585,222 | +20% | 0.02% | $118,892,744 |
| CITADEL ADVISORS LLC | 3.3% | 1,510,120 | +485% | 0.07% | $113,259,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8% | 1,287,240 | +5.6% | 0.01% | $96,559,855 |
| River Road Asset Management, LLC | 2.8% | 1,285,602 | -3.2% | 1.1% | $96,420,150 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.5% | 1,155,351 | -16% | 0.04% | $86,651,325 |
| T. Rowe Price Investment Management, Inc. | 2.4% | 1,101,371 | +84% | 0.05% | $82,603,000 |
| GOLDMAN SACHS GROUP INC | 2.3% | 1,046,019 | +9.8% | 0.01% | $78,451,463 |
| UBS Group AG | 2.2% | 983,378 | +87% | 0.01% | $73,753,350 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 1.8% | 830,925 | -1.2% | 0.31% | $62,319,375 |
| ROYAL BANK OF CANADA | 1.7% | 780,248 | -9.1% | 0.01% | $58,518,000 |
| Allspring Global Investments Holdings, LLC | 1.7% | 765,120 | -14% | 0.09% | $57,269,232 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.4% | 636,797 | +52% | 0% | $47,761,000 |
| DEUTSCHE BANK AG\ | 1.4% | 631,663 | +76% | 0.01% | $47,374,725 |
| NORTHERN TRUST CORP | 1.4% | 631,542 | +9% | 0.01% | $47,365,650 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.3% | 591,423 | +3.4% | 0.01% | $44,356,725 |
| Boston Trust Walden Corp | 1.3% | 585,148 | +17% | 0.33% | $43,886,100 |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 570,413 | +5730% | 0.03% | $42,780,975 |
| Holocene Advisors, LP | 1.2% | 550,195 | +12067% | 0.09% | $41,264,625 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 49,618,196 | $3,714,683,966 | +$181,716,307 | $75.00 | 328 |
| 2026 Q1 | 47,621,777 | $2,681,997,623 | -$232,314,744 | $56.36 | 324 |
| 2025 Q4 | 50,859,989 | $4,075,910,711 | +$58,180,392 | $80.15 | 329 |
| 2025 Q3 | 51,319,539 | $2,500,166,518 | -$232,706,500 | $48.74 | 298 |
| 2025 Q2 | 54,253,774 | $4,048,407,950 | +$51,089,014 | $74.61 | 297 |
| 2025 Q1 | 53,724,229 | $3,412,895,600 | -$212,763,194 | $63.55 | 313 |
| 2024 Q4 | 56,558,011 | $4,415,683,452 | +$40,389,204 | $78.08 | 305 |
| 2024 Q3 | 55,858,330 | $4,486,624,929 | -$21,003,128 | $80.38 | 303 |
| 2024 Q2 | 55,851,715 | $4,621,294,419 | +$385,980,667 | $82.73 | 315 |
| 2024 Q1 | 51,176,074 | $4,367,618,453 | +$50,781,270 | $85.35 | 296 |
| 2023 Q4 | 50,568,886 | $4,325,205,912 | -$20,996,057 | $85.51 | 294 |
| 2023 Q3 | 50,792,206 | $4,551,407,114 | +$20,351,169 | $89.58 | 294 |
| 2023 Q2 | 50,542,703 | $4,303,570,562 | +$14,249,115 | $85.14 | 288 |
| 2023 Q1 | 50,384,868 | $4,169,004,070 | +$9,612,280 | $82.75 | 294 |
| 2022 Q4 | 50,382,562 | $3,963,254,277 | -$107,357,997 | $78.65 | 287 |
| 2022 Q3 | 51,775,808 | $3,833,648,345 | -$28,085,090 | $74.03 | 260 |
| 2022 Q2 | 52,080,593 | $3,394,785,256 | +$49,689,135 | $65.18 | 229 |
| 2022 Q1 | 51,567,377 | $3,257,869,910 | +$120,748,445 | $63.22 | 225 |
| 2021 Q4 | 50,084,803 | $2,655,680,021 | -$87,203,336 | $53.04 | 240 |
| 2021 Q3 | 50,697,310 | $3,576,779,438 | +$7,330,940 | $70.59 | 239 |
| 2021 Q2 | 50,672,122 | $3,375,443,272 | -$52,557,812 | $66.64 | 249 |
| 2021 Q1 | 49,961,531 | $5,549,106,460 | -$22,300,347 | $111.01 | 288 |
| 2020 Q4 | 49,701,181 | $5,902,338,582 | +$13,637,273 | $118.75 | 278 |
| 2020 Q3 | 49,419,749 | $4,312,359,704 | -$6,823,951 | $87.25 | 261 |
| 2020 Q2 | 49,513,911 | $4,436,797,359 | -$134,065,133 | $89.56 | 276 |